Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Tetradecylthioacetic acid (TTA) is a synthetic fatty acid that has been studied primarily in animal models and limited human trials for its potential effects on lipid metabolism. TTA is known to act as a peroxisome proliferator-activated receptor (PPAR) agonist, particularly influencing PPAR-alpha, which plays a role in regulating genes involved in fatty acid oxidation and energy homeostasis. Preclinical studies in rodents have demonstrated that TTA can enhance fatty acid oxidation, reduce plasma triglycerides, and improve lipid profiles, suggesting a beneficial effect on fat metabolism. Small-scale human studies, such as those in patients with type 2 diabetes and metabolic syndrome, have shown modest improvements in lipid parameters, including some reduction in plasma triglyceride levels. However, results are inconsistent and the overall clinical significance remains unclear.

Despite encouraging preclinical data, evidence in humans is limited both in quality and quantity. There are no large-scale randomized controlled trials that confirm its efficacy for improving fat metabolism or treating related metabolic disorders. As a result, while there is a scientific basis for the use of TTA in supporting fat metabolism, the current level of evidence supporting its clinical use in humans is low to moderate at best. Further research is needed to determine its safety, efficacy, and potential therapeutic role in humans with poor fat metabolism.

More about Tetradecylthioacetic acid
More about Fat Metabolism (poor)

Other ingredients used for Fat Metabolism (poor)

Other health conditions supported by Tetradecylthioacetic acid

Products containing Tetradecylthioacetic acid